| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 118, 1952-1960, Copyright © 1986 by Endocrine Society
ARTICLES |
GA Dannan, DJ Porubek, SD Nelson, DJ Waxman and FP Guengerich
The participation of rat hepatic P-450 in the conversion of 17 beta- estradiol to catechol estrogens was examined by means of enzyme reconstitution and immunoinhibition studies. It was thus demonstrated that three rat liver microsomal cytochrome P-450 forms, designated P- 450UT-A, P-450PCN-E, and P-450ISF-G, each contribute to the 2- and 4- hydroxylation of 17 beta-estradiol catalyzed by hepatic microsomal preparations. Two of these enzymes, P-450UT-A and P-450PCN-E, are expressed constitutively, are male-specific, and are regulated by testosterone as well as influenced by the administration of various chemicals. Consistent with these observations, 17 beta-estradiol 2- and 4-hydroxylation activities both increased rapidly during puberty in male rats and were induced by treatment of rats with phenobarbital or pregnenolone 16 alpha-carbonitrile. Castration of male rats at birth or at 5 weeks of age suppressed the levels of 17 beta-estradiol 2- and 4- hydroxylase activities measured at 10 weeks of age. This suppression of activity was reversed upon administration of testosterone during the neonatal period (days 1 and 3 of life) or by capsule implantation at 5 weeks of age. These patterns of 17 beta-estradiol 2- and 4- hydroxylation are discussed in terms of the previously characterized response of the multiple rat hepatic P-450 forms to ontogenic, hormonal, and xenobiotic factors.
This article has been cited by other articles:
![]() |
L. F. Masson, L. Sharp, S. C. Cotton, and J. Little Cytochrome P-450 1A1 Gene Polymorphisms and Risk of Breast Cancer: A HuGE Review Am. J. Epidemiol., May 15, 2005; 161(10): 901 - 915. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshida, S. Katashima, J. Ando, T. Tanaka, F. Uematsu, D. Nakae, and A. Maekawa Dietary indole-3-carbinol promotes endometrial adenocarcinoma development in rats initiated with N-ethyl-N'-nitro-N-nitrosoguanidine, with induction of cytochrome P450s in the liver and consequent modulation of estrogen metabolism Carcinogenesis, November 1, 2004; 25(11): 2257 - 2264. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Lee, M. X. Cai, P. E. Thomas, A. H. Conney, and B. T. Zhu Characterization of the Oxidative Metabolites of 17{beta}-Estradiol and Estrone Formed by 15 Selectively Expressed Human Cytochrome P450 Isoforms Endocrinology, August 1, 2003; 144(8): 3382 - 3398. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Plowchalk and J. Teeguarden Development of a Physiologically Based Pharmacokinetic Model for Estradiol in Rats and Humans: A Biologically Motivated Quantitative Framework for Evaluating Responses to Estradiol and Other Endocrine-Active Compounds Toxicol. Sci., September 1, 2002; 69(1): 60 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mesia-Vela, R. I. Sanchez, J. J. Li, S. A. Li, A. H. Conney, and F. C. Kauffman Catechol estrogen formation in liver microsomes from female ACI and Sprague-Dawley rats: comparison of 2- and 4-hydroxylation revisited Carcinogenesis, August 1, 2002; 23(8): 1369 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Lee, L. H. Mills, J. W. Kosh, A. H. Conney, and B. T. Zhu NADPH-Dependent Metabolism of Estrone by Human Liver Microsomes J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 838 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Lee, J. W. Kosh, A. H. Conney, and B. T. Zhu Characterization of the NADPH-Dependent Metabolism of 17beta -Estradiol to Multiple Metabolites by Human Liver Microsomes and Selectively Expressed Human Cytochrome P450 3A4 and 3A5 J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 420 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. Badawi, E. L. Cavalieri, and E. G. Rogan Effect of chlorinated hydrocarbons on expression of cytochrome P450 1A1, 1A2 and 1B1 and 2- and 4-hydroxylation of 17{beta}-estradiol in female Sprague-Dawley rats Carcinogenesis, August 1, 2000; 21(8): 1593 - 1599. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Martin and B. L. Weber Genetic and Hormonal Risk Factors in Breast Cancer J Natl Cancer Inst, July 19, 2000; 92(14): 1126 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Mannisto and S. Kaakkola Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors Pharmacol. Rev., December 1, 1999; 51(4): 593 - 628. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |